These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8161471)

  • 21. The production of HlyA toxin by Proteus penneri strains.
    Senior BW
    J Med Microbiol; 1993 Oct; 39(4):282-9. PubMed ID: 8411089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent in vitro antitumor activity of B-subunit of Shiga toxin conjugated to the diphtheria toxin against breast cancer.
    Mohseni Z; Sedighian H; Halabian R; Amani J; Behzadi E; Imani Fooladi AA
    Eur J Pharmacol; 2021 May; 899():174057. PubMed ID: 33753109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of a non toxic chimeric protein (L1-L2-B) of Haemolysin BL from Bacillus cereus and its application in HBL toxin detection.
    Kumar TD; Murali HS; Batra HV
    J Microbiol Methods; 2008 Dec; 75(3):472-7. PubMed ID: 18718851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Escherichia coli hemolysin secretion apparatus--a versatile antigen delivery system in attenuated Salmonella.
    Gentschev I; Dietrich G; Mollenkopf HJ; Sokolovic Z; Hess J; Kaufmann SH; Goebel W
    Behring Inst Mitt; 1997 Feb; (98):103-13. PubMed ID: 9382730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
    Yang XL; Liu WC; Yang WW; Zhong D; Liu YH; Zhang JD; Jiang JH; Li SS
    Biomed Environ Sci; 2005 Dec; 18(6):411-8. PubMed ID: 16544523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The immunomodulating activity of Shigella dysenteriae 1 strains differing by their capacity for invasion and Shiga toxin production].
    Nikolaeva TN; Bondarenko VM
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):57-8. PubMed ID: 8553759
    [No Abstract]   [Full Text] [Related]  

  • 27. Conversion of bacterial gene products to secretion-competent fusion proteins.
    Mollenkopf HJ; Gentschev I; Goebel W
    Biotechniques; 1996 Nov; 21(5):854, 856-60. PubMed ID: 8922626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Shiga toxin subunit association by using hybrid A polypeptides and site-specific mutagenesis.
    Jemal C; Haddad JE; Begum D; Jackson MP
    J Bacteriol; 1995 Jun; 177(11):3128-32. PubMed ID: 7768810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carrier potential properties of Bacillus thuringiensis Cry1A toxins for a diphtheria toxin epitope.
    Guerrero GG; Moreno-Fierros L
    Scand J Immunol; 2007 Dec; 66(6):610-8. PubMed ID: 17949406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate.
    Delfani S; Mohabati Mobarez A; Imani Fooladi AA; Amani J; Emaneini M
    Med Microbiol Immunol; 2016 Feb; 205(1):47-55. PubMed ID: 26155981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Environmental regulation of alpha-haemolysin expression in Escherichia coli.
    Mouriño M; Muñoa F; Balsalobre C; Diaz P; Madrid C; Juarez A
    Microb Pathog; 1994 Apr; 16(4):249-59. PubMed ID: 7968454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The biochemistry of hemolysin toxin activation: characterization of HlyC, an internal protein acyltransferase.
    Trent MS; Worsham LM; Ernst-Fonberg ML
    Biochemistry; 1998 Mar; 37(13):4644-52. PubMed ID: 9521785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative immunogenicity of M. hyopneumoniae NrdF encoded in different expression systems delivered orally via attenuated S. typhimurium aroA in mice.
    Chen AY; Fry SR; Forbes-Faulkner J; Daggard GE; Mukkur TK
    Vet Microbiol; 2006 May; 114(3-4):252-9. PubMed ID: 16426773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of incompatible plasmids to control expression of antigen by Salmonella typhimurium and analysis of immunogenicity in mice.
    Ervin SE; Small PA; Gulig PA
    Microb Pathog; 1993 Aug; 15(2):93-101. PubMed ID: 8255210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis and genetic manipulation of Shigella virulence determinants for vaccine development.
    Mills SD; Sekizaki T; Gonzalez-Carrero MI; Timmis KN
    Vaccine; 1988 Apr; 6(2):116-22. PubMed ID: 3291449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction, expression, and immunogenicity of multiple tandem copies of the Schistosoma mansoni peptide 115-131 of the P28 glutathione S-transferase expressed as C-terminal fusions to tetanus toxin fragment C in a live aro-attenuated vaccine strain of Salmonella.
    Khan CM; Villarreal-Ramos B; Pierce RJ; Demarco de Hormaeche R; McNeill H; Ali T; Chatfield S; Capron A; Dougan G; Hormaeche CE
    J Immunol; 1994 Dec; 153(12):5634-42. PubMed ID: 7527446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shiga/verocytotoxins and Shiga/verotoxigenic Escherichia coli in animals.
    Mainil J
    Vet Res; 1999; 30(2-3):235-57. PubMed ID: 10367357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
    Huang Y; Hajishengallis G; Michalek SM
    Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carboxy-terminal peptides from the B subunit of Shiga toxin induce a local and parenteral protective effect.
    Harari I; Arnon R
    Mol Immunol; 1990 Jul; 27(7):613-21. PubMed ID: 2203962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of Shigella dysenteriae toxin formation at different stages in the forming of the cellular immune response in experimental animals].
    Nikolaeva TN; Bondarenko VM; Pronin AV
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):6-10. PubMed ID: 9245145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.